- Is there any vindication for low dose nonselective beta-blocker medication in patients with liver cirrhosis?
-
Kim TW, Kim HJ, Chon CU, Won HS, Park JH, Park DI, Cho YK, Sohn CI, Jeon WK, Kim BI
- KMID: 1743728
- Clin Mol Hepatol.
- 2012 Jun;18(2):203-212.
- doi: 10.3350/cmh.2012.18.2.203
BACKGROUND/AIMS: Nonselective beta-blockers (NSBBs), such as propranolol, reportedly exert a pleiotropic effect in liver cirrhosis. A previous report suggested that survival was higher in patients receiving adjusted doses of NSBBs... -
- CITED
-
- Close
- SHARE
-
- Close
